Literature DB >> 30910990

Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria.

Martin Greco1, María Jesus García de Yébenes2, Inmaculada Alarcón3, Anahy María Brandy-García4, Íñigo Rúa-Figueroa5, Estibaliz Loza2, Loreto Carmona2.   

Abstract

Entities:  

Keywords:  autoantibodies; autoimmune diseases; dermatomyositis; polymyositis

Mesh：

Substances：

Year:  2019        PMID： 30910990     DOI： 10.1136/annrheumdis-2019-215031

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

Review 1.  A multidisciplinary approach to the diagnosis of antisynthetase syndrome.

Authors:  Matthew Wells; Sughra Alawi; Kyaing Yi Mon Thin; Harsha Gunawardena; Adrian R Brown; Anthony Edey; John D Pauling; Shaney L Barratt; Huzaifa I Adamali
Journal:  Front Med (Lausanne)       Date:  2022-09-14

2.  Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria.

Authors:  Fergus To; Matthew J S Parker; Clara Ventín-Rodríguez; James B Lilleker; Hector Chinoy
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

3.  Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies.

Authors:  Ga Young Ahn; Chang Hee Suh; Yong Gil Kim; Yong Beom Park; Seung Cheol Shim; Sang Heon Lee; Shin Seok Lee; Sang Cheol Bae; Dae Hyun Yoo
Journal:  J Korean Med Sci       Date:  2020-09-28       Impact factor: 2.153
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.